Nexeon Medsystems Inc (NXNN) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1910 PACIFIC AVENUE, SUITE 20000 DALLAS, TX 75201 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2018 MRQ | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 884 | 2,040 | |||
| Cash and cash equivalents | 884 | 2,040 | |||
| Receivables | 1,878 | ||||
| Inventory, net of allowances, customer advances and progress billings | 2,207 | ||||
| Inventory | 2,207 | ||||
| Other current assets | 158 | 128 | |||
| Other undisclosed current assets | 804 | ||||
| Total current assets: | 5,930 | 2,168 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | 3,570 | 1 | |||
| Long-term investments and receivables | 149 | ||||
| Long-term investments | 149 | ||||
| Intangible assets, net (including goodwill) | 8,747 | ||||
| Intangible assets, net (excluding goodwill) | 8,747 | ||||
| Other undisclosed noncurrent assets | 10,852 | ||||
| Total noncurrent assets: | 14,421 | 8,897 | |||
| TOTAL ASSETS: | 20,351 | 11,065 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,079 | 148 | |||
| Interest and dividends payable | 2 | ||||
| Accounts payable | 2,575 | 112 | |||
| Accrued liabilities | 504 | 33 | |||
| Debt | 866 | 15 | |||
| Deferred tax liabilities | 174 | ||||
| Due to related parties | 0 | ||||
| Other undisclosed current liabilities | 1,014 | ||||
| Total current liabilities: | 5,134 | 163 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 10 | ||||
| Due to related parties | 10 | ||||
| Other undisclosed noncurrent liabilities | 3,349 | ||||
| Total noncurrent liabilities: | 3,349 | 10 | |||
| Total liabilities: | 8,482 | 173 | |||
| Equity | |||||
| Equity, attributable to parent, including: | 11,869 | 10,891 | |||
| Common stock | 28 | 22 | |||
| Additional paid in capital | 15,498 | 9,392 | |||
| Accumulated other comprehensive income | 21 | ||||
| Accumulated deficit | (3,743) | (1,592) | |||
| Other additional capital | 3,070 | ||||
| Other undisclosed equity, attributable to parent | 66 | ||||
| Total equity: | 11,869 | 10,891 | |||
| TOTAL LIABILITIES AND EQUITY: | 20,351 | 11,065 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2018 TTM | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|
| Revenues | 3,303 | |||
| Cost of revenue (Cost of Goods and Services Sold) | (2,322) | |||
| Gross profit: | 981 | |||
| Operating expenses | (4,129) | (1,412) | ||
| Other undisclosed operating loss | (2,943) | |||
| Operating loss: | (6,091) | (1,412) | ||
| Nonoperating expense (Investment Income, Nonoperating) | (72) | (174) | ||
| Interest and debt expense | (114) | (6) | ||
| Loss from continuing operations before equity method investments, income taxes: | (6,277) | (1,591) | ||
| Other undisclosed income from continuing operations before income taxes | 4,100 | |||
| Loss from continuing operations before income taxes: | (2,178) | (1,591) | ||
| Income tax expense | (636) | |||
| Loss from continuing operations: | (2,178) | (2,227) | ||
| Loss before gain (loss) on sale of properties: | (2,178) | (2,227) | ||
| Net loss: | (2,178) | (2,227) | ||
| Other undisclosed net income attributable to parent | 636 | |||
| Net loss available to common stockholders, diluted: | (2,178) | (1,591) | ||
Comprehensive Income ($ in thousands)
| 9/30/2018 TTM | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|
| Net loss: | (2,178) | (2,227) | ||
| Comprehensive loss: | (2,178) | (2,227) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (16) | |||
| Comprehensive loss, net of tax, attributable to parent: | (2,193) | (2,227) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.